Drug Database
Back to search

Poland· PL-100002444

Aclotin

A ticlopidine product containing ticlopidini hydrochloridum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 7 of our 19 countries.

ATC B01AC05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAclotinATCB01AC05REGISTER NO.PL-100002444PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ticlopidini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ticlopidine is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AC05 (ticlopidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search ticlopidine products by name

Ticlopidine · ATC B01AC05

7 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticlopidine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.25 in Italy to $1.0 in France — a ×4.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ticlopidine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.0
  • ES Spain$0.71
  • IT Italy$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ticlopidini hydrochloridum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
B01AC05
ATC class
Ticlopidine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

2 priced
  • gtin
    05909990667116
    20 szt.
    PLN 13.35
  • gtin
    05909990334971
    60 szt.
    PLN 35.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for ticlopidine.

Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ticlopidine against other medicinesHow interaction checks work

Ticlopidine · interactions on record

318 records

  • 54 severe
  • 124 moderate
  • 36 minor
  • 104 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticlopidine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticlopidine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Ticlid, Ticlopidine Teva
  • Germany · Ticlopidin Neuraxpharm, Ticlopidine Ratiopharm
  • Spain · Ticlopidina Cinfa
  • France · Ticlopidine Arrow, Ticlopidine Eg
  • Greece · Ruxicolan Cap
  • Hungary · Aclotin, Ticlid
  • Italy · Chiaro, Clox
  • Luxembourg · Ticlid
  • Portugal · Ticlopidina, Ticlopidina Alter
  • Romania · Ticlodin
  • Slovakia · Ticlopidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/038bbf1e-a0d4-4573-a4ff-2e8e73e4609e
GET /v1/drugs/038bbf1e-a0d4-4573-a4ff-2e8e73e4609e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990667116 ¦ Rp ¦ 419\n20 tabl.\n05909990334971 ¦ Rp ¦ 27880\n60 tabl.",
  "substance": "Ticlopidini hydrochloridum 250 mg",
  "common_name": "Ticlopidini hydrochloridum",
  "pl_product_id": "100002444",
  "pozwolenie_nr": "06671",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about ticlopidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console